InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,368.88
(
0.19%
)
Post# of 252302
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BioSpecialist

Send PM Follow Ignore
Followers 129
Posts 2150
Boards Moderated 1
Alias Born 12/27/2007

BioSpecialist

Re: None

Wednesday, 03/26/2008 8:42:03 AM

Wednesday, March 26, 2008 8:42:03 AM

Post# of 252302
Stem Cell Therapeutics--Great Interview

Marketcap: 26 million C$
Cash: 15 million C$
Price: 0,26 C$

After a successful phase II, Stem Cell Therapeutics is confident that it can regenerate the same results in new Canadian trials. BNN interviews Alan Moore, president and CEO, Stem Cell Therapeutics.
http://broadband.bnn.ca/bnn/?sid=205&vid=40429 <<click to listen

Homepage
http://www.stemcellthera.com/
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up